The project was featured among 23 selected individual Marie Curie Fellowship recipients in a publication issued in Brussels entitled EU FP7 People Specific Programme Success Stories Booklet, in which a total of 45 successful Marie Curie projects throughout Europe were presented.

Dr. Vianello obtained this prestigious and exceptionally competitive FP7 project in the 2009 EU competition, the first and only RBI scientist to do so until now. The project was implemented in the group of Dr. Janez Mavri at the National Institute of Chemistry in Ljubljana.

The main objective of the project was to use modern computer methods to improve understanding of the biocatalysis process, i.e., the way in which enzymes perform the function of the degradation of molecules during metabolism, which is one of the fundamental directions of science worldwide. One of the main achievements of this project is the computer elucidation of the mechanisms of catalytic activities and the inhibition of the enzyme monamine oxidase, which represents a significant step toward the development of new antidepressants and antiparkinsonians needed by a growing number of patients, especially in the more developed countries.

During and prior to the implementation of this project, Dr. Vianello received significant recognition from the European Commission as the 50,000th recipient of the Marie Curie Fellowship, when he was chosen from among all the project leaders at the time from throughout Europe, together with 24 colleagues, to represent all the 50,000 recipients of Marie Curie Fellowships to date from the inauguration of this program in 1996.

EU FP7 People Specific Programme Success Stories Booklet: